Physician profile
David S Kwon
NPI 1740577055
$5,237.65
in general payments reported to CMS, 2019-2025
14 companies · $1,192 in 2025
The $1,192 reported for 2025 was more than what 84% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $865 · 2022: $1,081 · 2023: $1,108 · 2024: $993 · 2025: $1,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,292.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,370.00 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,148.02 | 2021-2025 | Caplyta |
| Axsome Therapeutics, INC. | $572.79 | 2023-2025 | Auvelity |
| Alkermes, INC. | $396.55 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $374.19 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $371.40 | 2021-2023 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $365.72 | 2024-2025 | Cobenfy |
| Boston Scientific Corporation | $147.50 | 2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Olympus America INC. | $135.03 | 2025 | Single Use Electrosurgical Knife Kd-655 |
| Steris Corporation | $116.92 | 2025 | |
| Biogen, INC. | $115.20 | 2025 | Zurzuvae |
| Lundbeck LLC | $87.73 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $23.28 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.